NCT00171132View on ClinicalTrials.gov

VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Hypertension
Interventions
DRUG

valsartan

DRUG

atenolol

DRUG

hydrochlorothiazide

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY